Public Release Summary on the evaluation of the new active zilpaterol hydrochloride in the product Zilmax Medicated Premix

At the request of stakeholders, we have extended the consultation closing date to 23 June 2020.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.